Literature DB >> 28956609

Learning Medicinal Chemistry Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) Rules from Cross-Company Matched Molecular Pairs Analysis (MMPA).

Christian Kramer1, Attilla Ting2, Hao Zheng3, Jérôme Hert1, Torsten Schindler1, Martin Stahl1, Graeme Robb2, James J Crawford3, Jeff Blaney3, Shane Montague4, Andrew G Leach4, Al G Dossetter4, Ed J Griffen4.   

Abstract

The first large scale analysis of in vitro absorption, distribution, metabolism, excretion, and toxicity (ADMET) data shared across multiple major pharma has been performed. Using advanced matched molecular pair analysis (MMPA), we combined data from three pharmaceutical companies and generated ADMET rules, avoiding the need to disclose the full chemical structures. On top of the very large exchange of knowledge, all companies involved synergistically gained approximately 20% more rules from the shared transformations. There is good quantitative agreement between the rules based on shared data compared to both individual companies' rules and rules published in the literature. Known correlations between log  D, solubility, in vitro clearance, and plasma protein binding also hold in transformation space, but there are also interesting exceptions. Data pools such as this allow focusing on particular functional groups and characterizing their ADMET profile. Finally the role of a corpus of robustly tested medicinal chemistry knowledge in the training of medicinal chemistry is discussed.

Entities:  

Mesh:

Year:  2017        PMID: 28956609     DOI: 10.1021/acs.jmedchem.7b00935

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Strategy for Extending Half-life in Drug Design and Its Significance.

Authors:  Hakan Gunaydin; Michael D Altman; J Michael Ellis; Peter Fuller; Scott A Johnson; Brian Lahue; Blair Lapointe
Journal:  ACS Med Chem Lett       Date:  2018-04-02       Impact factor: 4.345

2.  Why Decreasing Lipophilicity Alone Is Often Not a Reliable Strategy for Extending IV Half-life.

Authors:  Fabio Broccatelli; Ignacio Aliagas; Hao Zheng
Journal:  ACS Med Chem Lett       Date:  2018-04-19       Impact factor: 4.345

3.  LogD Contributions of Substituents Commonly Used in Medicinal Chemistry.

Authors:  Matthew L Landry; James J Crawford
Journal:  ACS Med Chem Lett       Date:  2019-12-11       Impact factor: 4.345

4.  Computational quantum chemistry, molecular docking, and ADMET predictions of imidazole alkaloids of Pilocarpus microphyllus with schistosomicidal properties.

Authors:  Jefferson A Rocha; Nayra C S Rego; Bruna T S Carvalho; Francisco I Silva; Jose A Sousa; Ricardo M Ramos; Ionara N G Passos; Josué de Moraes; Jose R S A Leite; Francisco C A Lima
Journal:  PLoS One       Date:  2018-06-26       Impact factor: 3.240

5.  Potent bicyclic inhibitors of malarial cGMP-dependent protein kinase: approaches to combining improvements in cell potency, selectivity and structural novelty.

Authors:  Jonathan M Large; Kristian Birchall; Nathalie S Bouloc; Andy T Merritt; Ela Smiljanic-Hurley; Denise J Tsagris; Mary C Wheldon; Keith H Ansell; Peter J Coombs; Catherine A Kettleborough; David Whalley; Lindsay B Stewart; Paul W Bowyer; David A Baker; Simon A Osborne
Journal:  Bioorg Med Chem Lett       Date:  2019-08-09       Impact factor: 2.823

Review 6.  Chalcone Scaffolds, Bioprecursors of Flavonoids: Chemistry, Bioactivities, and Pharmacokinetics.

Authors:  Mithun Rudrapal; Johra Khan; Abdul Aziz Bin Dukhyil; Randa Mohammed Ibrahim Ismail Alarousy; Emmanuel Ifeanyi Attah; Tripti Sharma; Shubham Jagdish Khairnar; Atul Rupchand Bendale
Journal:  Molecules       Date:  2021-11-26       Impact factor: 4.411

7.  Exploring flexibility, intermolecular interactions and ADMET profiles of anti-influenza agent isorhapontigenin: A quantum chemical and molecular docking study.

Authors:  Sathya Bangaru; Govindammal Madhu; M Srinivasan; Prasath Manivannan
Journal:  Heliyon       Date:  2022-08-12

8.  Design, Synthesis, and Evaluation of New Mesenchymal-Epithelial Transition Factor (c-Met) Kinase Inhibitors with Dual Chiral Centers.

Authors:  Han Yao; Yuanyuan Ren; Jun Yan; Jiadai Liu; Jinhui Hu; Ming Yan; Xingshu Li
Journal:  Molecules       Date:  2022-08-23       Impact factor: 4.927

9.  Computational and In Vitro Investigation of (-)-Epicatechin and Proanthocyanidin B2 as Inhibitors of Human Matrix Metalloproteinase 1.

Authors:  Kyung Eun Lee; Shiv Bharadwaj; Umesh Yadava; Sang Gu Kang
Journal:  Biomolecules       Date:  2020-09-28

Review 10.  Crowdsourcing and open innovation in drug discovery: recent contributions and future directions.

Authors:  David C Thompson; Jörg Bentzien
Journal:  Drug Discov Today       Date:  2020-10-02       Impact factor: 7.851

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.